Ana Lazic

Ana Lazic is a seasoned professional with a track record of successfully leading the commercialization of foreign life-science technologies in the United States. Her expertise includes new product development, life science technology evaluation, business development, project management, market penetration, and client relations.

Ana Lazic possesses a wealth of knowledge and proficiency in areas such as protein biochemistry (including structural biology and enzymology) and biophysics (covering techniques like MicroScale Thermophoresis, ITC, DSC, AUC, spectroscopy, and nanoDSF). Her skill set also extends to drug discovery and development, HTS/HCA, biomarker discovery, oncology, and 3D cell culture.

In terms of her education, Ana Lazic pursued a Doctor of Philosophy at the University of Kragujevac, Philosophy at the University of Illinois at Chicago, a Doctor of Philosophy in Biochemistry and Biology at the University of Illinois at Chicago, and a Bachelor of Science in Biochemistry at the University of Belgrade.

Currently serving as the Chief Operating Officer at NanoTemper Technologies, Ana Lazic continues to drive innovation and lead advancements in the field of life sciences technology.